Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tetrandrine + MTX vs MTX in RA
NCT05245448Unknown
- Sponsor
- Peking University People's Hospital
- Start
- Feb 2022
- Primary completion
- Oct 2023
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in rheumatoid arthritis (RA) comparing Tetrandrine with Placebo -> Tetrandrine (2 arms). Primary endpoint: American College of Rheumatology 20% Improvement at 12 weeks. Status: unknown.
02
Drugs
tetrandrine
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT05245448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05245448.